Psybio logo.png
Miami University Researchers Collaborate with PsyBio Therapeutics to Biosynthetically Produce Psilocybin, the Psychedelic Ingredient in Magic Mushrooms, and Other Psychoactive Drug Candidates to Treat Mental Health Challenges
May 22, 2020 08:30 ET | PsyBio Therapeutics Inc.
OXFORD, Ohio, May 22, 2020 (GLOBE NEWSWIRE) -- via NetworkWire – Miami University in Oxford, Ohio, and PsyBio Therapeutics Inc. (“PsyBio”) www.psybiolife.com are collaborating to develop a new and...